The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

被引：0
|
作者：
W Ingram
N C Lea
J Cervera
U Germing
P Fenaux
B Cassinat
J J Kiladjian
J Varkonyi
P Antunovic
N B Westwood
M J Arno
A Mohamedali
J Gaken
T Kontou
B H Czepulkowski
N A Twine
J Tamaska
J Csomer
S Benedek
N Gattermann
E Zipperer
A Giagounidis
Z Garcia-Casado
G Sanz
G J Mufti
机构：
[1] Kings College Hospital and Kings College London,Department of Haematological Medicine
[2] The Servicio de Hematologia y Hemoterapia,Department of Haematology
[3] Hospital Universitario La Fe,Third Department of Internal Medicine
[4] Oncology and Clinical Immunology,Department of Haematology
[5] Heinrich-Heine-University,Department of Oncology and Clinical Immunology
[6] Hematology Department at Hopital Avicenne,undefined
[7] Semmelweis University,undefined
[8] University Hospital Linköping,undefined
[9] Genomics center,undefined
[10] School of Biomedical and Health Sciences,undefined
[11] Kings College London,undefined
[12] National Health Centre,undefined
[13] Semmelweis University,undefined
[14] Institute of Pathology and Cancer Research,undefined
[15] Semmelweis University,undefined
[16] St-Johannes-Hospital,undefined
来源：
Leukemia | 2006年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1319 / 1321
页数：2
相关论文
共 50 条
  • [31] KINETICS OF JAK2 V617F MUTATION IN FIVE JAK2 POSITIVE MDS PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Alchalby, H.
    Badbaran, A.
    Lioznov, M.
    Zander, A. R.
    Kroeger, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 462 - 462
  • [32] Screening of JAK2 V617F mutation in multiple myeloma
    A Fiorini
    G Farina
    G Reddiconto
    M Palladino
    E Rossi
    T Za
    L Laurenti
    S Giammarco
    P Chiusolo
    G Leone
    S Sica
    Leukemia, 2006, 20 : 1912 - 1913
  • [33] JAK2 V617F mutation in essential thrombocythemia.
    Ahn, Jeong Yeal
    Park, Pil Whan
    Seo, Yiel Hea
    Shin, Dong-Bok
    Lee, Jae-Hoon
    Yoo, Soo-Jin
    Bang, Soo-Mee
    BLOOD, 2006, 108 (11) : 318B - 318B
  • [34] Screening of JAK2 V617F mutation in multiple myeloma
    Fiorini, A.
    Farina, G.
    Reddiconto, G.
    Palladino, M.
    Rossi, E.
    Za, T.
    Laurenti, L.
    Giammarco, S.
    Chiusolo, P.
    Leone, G.
    Sica, S.
    LEUKEMIA, 2006, 20 (10) : 1912 - 1913
  • [35] Chronic Neutrophilic Leukemia with V617F JAK2 Mutation
    Gajendra, Smeeta
    Gupta, Ritu
    Chandgothia, Meenal
    Kumar, Lalit
    Gupta, Richa
    Chavan, Snehal Motilal
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 (02) : 139 - 142
  • [36] Chronic Neutrophilic Leukemia with V617F JAK2 Mutation
    Smeeta Gajendra
    Ritu Gupta
    Meenal Chandgothia
    Lalit Kumar
    Richa Gupta
    Snehal Motilal Chavan
    Indian Journal of Hematology and Blood Transfusion, 2014, 30 : 139 - 142
  • [37] No evidence for JAK2 V617F mutation in colorectal cancer
    Herreros-Villanueva, M.
    Garcia-Giron, C.
    Er, T-K
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2010, 67 (04) : 220 - 222
  • [38] JAK2 V617F is associated with 5q-syndrome in Chinese
    Wong, K.
    Wong, W.
    Siu, L.
    Lau, T.
    Chan, N.
    CHROMOSOME RESEARCH, 2009, 17 : 114 - 114
  • [39] V617F mutation in JAK2 is associated idiopathic myelofibrosis
    Campbell, PJ
    Griesshammer, M
    Döhner, K
    Döhner, H
    Kusec, R
    Hasselbalch, HC
    Larsen, TS
    Pallisgaard, N
    Giraudier, S
    Le Bousse-Kerdilès, MC
    Desterke, C
    Guerton, B
    Dupriez, B
    Bordessoule, D
    Fenaux, P
    Kiladjian, JJ
    Viallard, JF
    Brière, J
    Harrison, CN
    Green, AR
    Reilly, JT
    BLOOD, 2006, 107 (05) : 2098 - 2100
  • [40] Association of V617F JAK2 mutation and myelodysplastic 5q-syndrome without anemia
    Espanel, C.
    Herault, O.
    Kafando, E.
    Bacq, Y.
    Barin, C.
    Petit, A.
    Binet, C.
    Domenech, J.
    LEUKEMIA RESEARCH, 2007, 31 : S140 - S141
12345